The global cannabis testing services market size is expected to reach USD 7.19 billion by 2033, registering a CAGR of 14.36% from 2026 to 2033, according to a new report by Grand View Research, Inc. Several nations across the globe have legalized cannabis for medical and recreational purposes, which has led to the recognition of the medicinal benefits of cannabis and cannabis-infused products. For instance, in April 2024, Germany legalized cannabis for recreational purposes, and under this law, adults over 18 can possess 25 grams of dried cannabis and grow up to three marijuana plants at home. Moreover, research has revealed that cannabis can provide significant relief from adverse effects, such as chronic pain associated with multiple sclerosis and chemotherapy-induced nausea. Such factors boost market growth.
Cannabis extracts are utilized to treat multiple mental and neurological disorders. With the growing incidence of these disorders, along with the rise in the production and use of cannabis, the cannabis testing market is anticipated to grow during the forecast period. For instance, according to data published by the Institute for Health Metrics and Evaluation, in 2021, neurological disorders emerged as the leading cause of global disease burden, affecting 43% of the population (3.4 billion people) and accounting for 443 million disability-adjusted life years lost, surpassing cardiovascular diseases.
In addition, several countries, such as the U.S., Brazil, France, and Germany, have modified their national controls to accommodate cannabidiol as a medicinal product. Also, increasing awareness about the medical benefits of cannabidiol is anticipated to drive product demand in the pharmaceutical industry. This, in turn, is increasing demand for cannabis testing services from the pharmaceutical industry to ensure the purity and potency of cannabis. For example, major players in the pharmaceutical industry, including Charlotte's Web, Jazz Pharmaceuticals plc. Isodiol International, and CannaHealth, among others, are using cannabidiol for manufacturing tinctures and capsules.
Some of the key players in the market are Saskatchewan Research Council (SRC), SC Labs, SGS Société Générale de Surveillance SA (SGS Canada Inc.), Dr. Robert Shrewsbury & the UNC Eshelman School of Pharmacy (PharmLabs), Greenleaf Testing Laboratory and Eurofins Scientific. Players are adopting key strategic initiatives to expand their business and market position. For instance, in May 2023, Smithers, a testing, information, consulting, and compliance services provider, entered the Arizona cannabis testing market by acquiring Green Scientific Labs’ operations in Arizona.
Request a free sample copy or view report summary: Cannabis Testing Services Market Report
The potency testing segment dominated the cannabis testing services market in 2025, accounting for the largest revenue share of 23.48%.
The cannabis cultivators/growers segment dominated the cannabis testing services industry in 2025, accounting for a revenue share of 61.05%.
North America dominated the cannabis testing services market in 2025, accounting for the largest revenue share of 54.10%.
The Asia Pacific cannabis testing services industry is expected to grow at the fastest CAGR over the forecast period.
Grand View Research has segmented the global cannabis testing services market on the basis of services, end use and region:
Cannabis Testing Services Service Outlook (Revenue, USD Million, 2021 - 2033)
Potency Testing
Terpene Profiling
Heavy Metal Testing
Pesticide Screening
Microscopy Testing
Residual Solvent Screening
Others
Cannabis Testing Services End Use Outlook (Revenue, USD Million, 2021 - 2033)
Cannabis Cultivators/Growers
Cannabis Drug Manufacturers
Others (Research Institutes & Labs)
Cannabis Testing Services Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
Italy
Poland
Czech Republic
Switzerland
Croatia
Netherlands
Spain
Asia Pacific
China
Japan
India
Thailand
Australia
New Zealand
Latin America and Caribbean
Brazil
Uruguay
Colombia
Africa
List of Key Players in the Cannabis Testing Services Market
Saskatchewan Research Council (SRC)
SC Labs
SGS Société Générale de Surveillance SA (SGS Canada Inc.)
Dr. Robert Shrewsbury & the UNC Eshelman School of Pharmacy (PharmLabs)
GREEN LEAF LAB
Eurofins Scientific
PhytoVista Laboratories (BRITISH CANNABIS GROUP)
BRITISH CANNABIS
ADACT Medical Ltd.
Laboratorium Dr. Liebich
AZ Biopharm GmbH
"The quality of research they have done for us has been excellent..."